APA

Uematsu A., Kido K., Manabe E., Takeda H., Takahashi H., Hayashi M., Imai Y. & Sawasaki T. (20180214). DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma. : Biochemical and biophysical research communications.

Chicago

Uematsu Atsushi, Kido Kohki, Manabe Erika, Takeda Hiroyuki, Takahashi Hirotaka, Hayashi Minoru, Imai Yuuki and Sawasaki Tatsuya. 20180214. DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma. : Biochemical and biophysical research communications.

Harvard

Uematsu A., Kido K., Manabe E., Takeda H., Takahashi H., Hayashi M., Imai Y. and Sawasaki T. (20180214). DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma. : Biochemical and biophysical research communications.

MLA

Uematsu Atsushi, Kido Kohki, Manabe Erika, Takeda Hiroyuki, Takahashi Hirotaka, Hayashi Minoru, Imai Yuuki and Sawasaki Tatsuya. DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma. : Biochemical and biophysical research communications. 20180214.